Saltar al contenido
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Lenguaje
Todos los Campos
Título
Autor
Materia
Número de Clasificación
ISBN/ISSN
Etiqueta
Buscar
Avanzado
Inability to Tolerate Standard...
Citar
Describir
Enviar este por Correo electrónico
Imprimir
Exportar Registro
Exportar a RefWorks
Exportar a EndNoteWeb
Exportar a EndNote
Enlace Permanente
Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial
Mostrar otras versiones (2)
Detalles Bibliográficos
Autores principales:
Sive, J
,
Buck, G
,
Fielding, A
,
Lazarus, H
,
Litzow, MR
,
Luger, S
,
Marks, D
,
McMillan, A
,
Richards, S
,
Rowe, J
,
Tallman, MS
,
Goldstone, A
Formato:
Conference item
Publicado:
2010
Existencias
Descripción
Otras Versiones (2)
Ejemplares similares
Vista Equipo
Ejemplares similares
Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial
por: Sive, J, et al.
Publicado: (2010)
Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL): Results From the International MRC/ECOG Trial
por: Sive, J, et al.
Publicado: (2010)
Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial.
por: Sive, J, et al.
Publicado: (2012)
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study.
por: Fielding, A, et al.
Publicado: (2007)
Imatinib Significantly Enhances Long-Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia; Final Results of the UKALLXII/ECOG2993 Trial
por: Fielding, A, et al.
Publicado: (2010)